Cardiovascular Disease Clinical Trial
Official title:
Identificación de la poBlación Española de RIesgo CArdiovascular y reNal
IBERICAN is a multicenter, longitudinal and observational population-based study of patients
daily attended in Primary Care setting in Spain.
This study is aimed to determine the prevalence and incidence of cardiovascular risk factors
in adult population in Spain.
Patients will be followed-up for a minimum period of 5 years, every 6 months or a lesser
period when clinically required.
It has been estimated that a total of 15,000 individuals will be included.
IBERICAN (Identificación de la poBlación Española de RIesgo CArdio Vascular y reNal) is a
multicenter, longitudinal and observational population-based study of patients daily
attended in Primary Care setting in Spain.
The aims of IBERICAN are to determine the prevalence and incidence of cardiovascular risk
factors in adult population in Spain. Moreover, the development of cardiovascular outcomes,
and risk factors control rates will be also analyzed.
In IBERICAN, subjects irrespective of the presence of risk factors or cardiovascular disease
throughout Spain will be included.
No specific recommendations will be provide to physicians about treatments. As a result,
treatments of patients will be prescribed, modified or withdrawn according only to
physicians´ judgment. The study has been approved by the ethic committee of Hospital Carlos
III, Madrid on February 2013. Before inclusion, every patient will provide a written
informed consent.
Patients will be followed-up for a minimum period of 5 years, every 6 months or a lesser
period when clinically required. Excepting a blood analysis in the previous 6 months before
the inclusion, no other specific diagnostic tool or technique will be required for being
included in the study. All blood and urine analysis or other techniques will be performed
according to clinical practice during the follow-up.
It has been estimated that a total of 15,000 individuals will be included.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
| Completed |
NCT02502812 -
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT04216342 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03654313 -
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
|
Phase 1 | |
| Completed |
NCT03646656 -
Heart Health Buddies: Peer Support to Decrease CVD Risk
|
N/A | |
| Completed |
NCT02081066 -
Identification of CETP as a Marker of Atherosclerosis
|
N/A | |
| Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
| Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
| Recruiting |
NCT03095261 -
Incentives in Cardiac Rehabilitation
|
N/A | |
| Completed |
NCT02868710 -
Individual Variability to Aerobic Exercise Training
|
N/A | |
| Not yet recruiting |
NCT02578355 -
National Plaque Registry and Database
|
N/A | |
| Completed |
NCT02711878 -
Healing Hearts and Mending Minds in Older Adults Living With HIV
|
N/A | |
| Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
| Completed |
NCT02998918 -
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
|
N/A | |
| Recruiting |
NCT02885792 -
Coronary Artery Disease in Patients Suffering From Schizophrenia
|
N/A | |
| Completed |
NCT02272946 -
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
|
Phase 2 | |
| Completed |
NCT02657382 -
Mental Stress Ischemia: Biofeedback Study
|
N/A | |
| Completed |
NCT02640859 -
Investigation of Metabolic Risk in Korean Adults
|
||
| Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
| Recruiting |
NCT02265250 -
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
|